Show Notes
What does it take to tackle the world’s most complex diseases? For David Price, head of the Vertex Pharmaceuticals Oxford Research site, the motivation is deeply personal.
In this podcast from New Scientist CoLab, David shares his incredible journey and gives a detailed look inside Vertex, the company that pioneered patient-first drug discovery.
Learn about their unique serial innovation strategy, which focuses on treating the underlying cause of a disease, not just the symptoms. He also discusses how automation and robotics are transforming the lab and why talented students and interns represent an extraordinary future.
Sponsored by Vertex Pharmaceuticals.
Learn more about your ad choices. Visit megaphone.fm/adchoices
More from New Scientist Colab Podcasts
💬 The longevity space isn’t just for humans. Science is uncovering new ways to keep our pets healthier for longer too. New research is finally uncovering why our dogs and cats slow down with age - and how we can slow that process.
💬 Over the last decade, advances in subsurface imaging have meant we’re able to see deep within our planet with unfathomable detail - pinpointing vast geological structures beneath our oceans with unprecedented accuracy.
The production of medicines is a high-stakes industry where efficiency and environmental impact often collide. Given that the pharmaceutical industry is one of society’s biggest polluters, solving this challenge requires massive, cross-continent collaboration to spark real change.